CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Steer clear of the worst practices in cryptocurrency investing to protect your assets. Learn from common mistakes.
12,710 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
A caller on a popular financial show describes paying off her boyfriend's $15,000 debt while living in his family hom...
When space stocks surge, investors want to know why. This article breaks down the drivers behind Planet Labs stock we...
A Live Oak Bancshares director sold 8,400 shares for about $336,000. Learn what this kind of insider action can signa...
A memory stock that looked ordinary just a year ago has stunned investors with an 8x move. Now Wall Street is unanimo...
Medicare will cover GLP-1 weight-loss drugs for eligible beneficiaries beginning this week, a policy shift that could...
Investors are debating whether d-wave's opportunity flag? marks a breakthrough or a trap. This guide breaks down the ...
Analysts expect a stronger cost-of-living adjustment in 2027, potentially lifting the average Social Security check b...
Two of the biggest oil players, COP and OXY, offer different paths for investors. This guide breaks down the differen...
Two blue-chip banks report divergent 2026 results: Morgan Stanley leans on wealth advisory, while JPMorgan runs a uni...